These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 25135652)

  • 1. A longitudinal study of urea cycle disorders.
    Batshaw ML; Tuchman M; Summar M; Seminara J;
    Mol Genet Metab; 2014; 113(1-2):127-30. PubMed ID: 25135652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving long term outcomes in urea cycle disorders-report from the Urea Cycle Disorders Consortium.
    Waisbren SE; Gropman AL; ; Batshaw ML
    J Inherit Metab Dis; 2016 Jul; 39(4):573-84. PubMed ID: 27215558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suggested guidelines for the diagnosis and management of urea cycle disorders: First revision.
    Häberle J; Burlina A; Chakrapani A; Dixon M; Karall D; Lindner M; Mandel H; Martinelli D; Pintos-Morell G; Santer R; Skouma A; Servais A; Tal G; Rubio V; Huemer M; Dionisi-Vici C
    J Inherit Metab Dis; 2019 Nov; 42(6):1192-1230. PubMed ID: 30982989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes of neonatal onset proximal versus distal urea cycle disorders do not differ.
    Ah Mew N; Krivitzky L; McCarter R; Batshaw M; Tuchman M;
    J Pediatr; 2013 Feb; 162(2):324-9.e1. PubMed ID: 22901741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome of urea cycle disorders: Report from a nationwide study in Japan.
    Kido J; Matsumoto S; Häberle J; Nakajima Y; Wada Y; Mochizuki N; Murayama K; Lee T; Mochizuki H; Watanabe Y; Horikawa R; Kasahara M; Nakamura K
    J Inherit Metab Dis; 2021 Jul; 44(4):826-837. PubMed ID: 33840128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infectious precipitants of acute hyperammonemia are associated with indicators of increased morbidity in patients with urea cycle disorders.
    McGuire PJ; Lee HS; ; Summar ML
    J Pediatr; 2013 Dec; 163(6):1705-1710.e1. PubMed ID: 24084106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical course of 63 patients with neonatal onset urea cycle disorders in the years 2001-2013.
    Unsinn C; Das A; Valayannopoulos V; Thimm E; Beblo S; Burlina A; Konstantopoulou V; Mayorandan S; de Lonlay P; Rennecke J; Derbinski J; Hoffmann GF; Häberle J
    Orphanet J Rare Dis; 2016 Aug; 11(1):116. PubMed ID: 27538463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges in diagnosing and managing adult patients with urea cycle disorders.
    Stepien KM; Geberhiwot T; Hendriksz CJ; Treacy EP
    J Inherit Metab Dis; 2019 Nov; 42(6):1136-1146. PubMed ID: 30932189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-sectional observational study of 208 patients with non-classical urea cycle disorders.
    Rüegger CM; Lindner M; Ballhausen D; Baumgartner MR; Beblo S; Das A; Gautschi M; Glahn EM; Grünert SC; Hennermann J; Hochuli M; Huemer M; Karall D; Kölker S; Lachmann RH; Lotz-Havla A; Möslinger D; Nuoffer JM; Plecko B; Rutsch F; Santer R; Spiekerkoetter U; Staufner C; Stricker T; Wijburg FA; Williams M; Burgard P; Häberle J
    J Inherit Metab Dis; 2014 Jan; 37(1):21-30. PubMed ID: 23780642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and treatment of urea cycle disorder in Japan.
    Nakamura K; Kido J; Mitsubuchi H; Endo F
    Pediatr Int; 2014 Aug; 56(4):506-9. PubMed ID: 25039902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are asymptomatic carriers of OTC deficiency always asymptomatic? A multicentric retrospective study of risk using the UCDC longitudinal study database.
    Sen K; Izem R; Long Y; Jiang J; Konczal LL; McCarter RJ; ; Gropman AL; Bedoyan JK
    Mol Genet Genomic Med; 2024 Apr; 12(4):e2443. PubMed ID: 38634223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome and intervention of urea cycle disorders in Japan.
    Kido J; Nakamura K; Mitsubuchi H; Ohura T; Takayanagi M; Matsuo M; Yoshino M; Shigematsu Y; Yorifuji T; Kasahara M; Horikawa R; Endo F
    J Inherit Metab Dis; 2012 Sep; 35(5):777-85. PubMed ID: 22167275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Diagnosis and Therapy on Cognitive Function in Urea Cycle Disorders.
    Posset R; Gropman AL; Nagamani SCS; Burrage LC; Bedoyan JK; Wong D; Berry GT; Baumgartner MR; Yudkoff M; Zielonka M; Hoffmann GF; Burgard P; Schulze A; McCandless SE; Garcia-Cazorla A; Seminara J; Garbade SF; Kölker S;
    Ann Neurol; 2019 Jul; 86(1):116-128. PubMed ID: 31018246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urea cycle disorders in Argentine patients: clinical presentation, biochemical and genetic findings.
    Silvera-Ruiz SM; Arranz JA; Häberle J; Angaroni CJ; Bezard M; Guelbert N; Becerra A; Peralta F; de Kremer RD; Laróvere LE
    Orphanet J Rare Dis; 2019 Aug; 14(1):203. PubMed ID: 31426867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased plasma l-arginine levels in organic acidurias (MMA and PA) and decreased plasma branched-chain amino acid levels in urea cycle disorders as a potential cause of growth retardation: Options for treatment.
    Molema F; Gleich F; Burgard P; van der Ploeg AT; Summar ML; Chapman KA; Lund AM; Rizopoulos D; Kölker S; Williams M;
    Mol Genet Metab; 2019 Apr; 126(4):397-405. PubMed ID: 30827756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium phenylbutyrate decreases plasma branched-chain amino acids in patients with urea cycle disorders.
    Burrage LC; Jain M; Gandolfo L; Lee BH; ; Nagamani SC
    Mol Genet Metab; 2014; 113(1-2):131-5. PubMed ID: 25042691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishing a consortium for the study of rare diseases: The Urea Cycle Disorders Consortium.
    Seminara J; Tuchman M; Krivitzky L; Krischer J; Lee HS; Lemons C; Baumgartner M; Cederbaum S; Diaz GA; Feigenbaum A; Gallagher RC; Harding CO; Kerr DS; Lanpher B; Lee B; Lichter-Konecki U; McCandless SE; Merritt JL; Oster-Granite ML; Seashore MR; Stricker T; Summar M; Waisbren S; Yudkoff M; Batshaw ML
    Mol Genet Metab; 2010; 100 Suppl 1(Suppl 1):S97-105. PubMed ID: 20188616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of medical management on growth and weight in individuals with urea cycle disorders.
    Posset R; Garbade SF; Gleich F; Gropman AL; de Lonlay P; Hoffmann GF; Garcia-Cazorla A; Nagamani SCS; Baumgartner MR; Schulze A; Dobbelaere D; Yudkoff M; Kölker S; Zielonka M; ;
    Sci Rep; 2020 Jul; 10(1):11948. PubMed ID: 32686765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of liver transplantation in urea cycle disorders: Report from a nationwide study in Japan.
    Kido J; Matsumoto S; Häberle J; Inomata Y; Kasahara M; Sakamoto S; Horikawa R; Tanemura A; Okajima H; Suzuki T; Nakamura K
    J Inherit Metab Dis; 2021 Nov; 44(6):1311-1322. PubMed ID: 34232532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspectives on urea cycle disorder management: Results of a clinician survey.
    Enns GM; Porter MH; Francis-Sedlak M; Burdett A; Vockley J
    Mol Genet Metab; 2019; 128(1-2):102-108. PubMed ID: 31377149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.